<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="23511,32460">Cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotrienes</z:chebi> (CysLTs) induce <z:mp ids='MP_0001845'>inflammatory responses</z:mp> by activating their receptors, CysLT(1)R and CysLT(2)R </plain></SENT>
<SENT sid="1" pm="."><plain>We recently reported that CysLT(2)R is involved in neuronal injury, <z:hpo ids='HP_0002446'>astrocytosis</z:hpo> and <z:mp ids='MP_0008918'>microgliosis</z:mp> after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we determined whether HAMI 3379, a selective CysLT(2)R <z:chebi fb="68" ids="48706">antagonist</z:chebi>, protects against <z:hpo ids='HP_0011009'>acute</z:hpo> brain injury after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="3" pm="."><plain>We induced transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by 30 min of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by 24h of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>HAMI 3379 (1, 10 or 100 ng) was injected intracerebroventricularly (i.c.v.) 30 min before MCAO, and the CysLT(1)R <z:chebi fb="68" ids="48706">antagonist</z:chebi> pranlukast (0.1mg/kg, i.p.) was used as a positive control </plain></SENT>
<SENT sid="5" pm="."><plain>HAMI 3379 at 10 and 100 ng (but not at 1 ng) attenuated the neurological deficits, and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:hpo ids='HP_0002181'>brain edema</z:hpo>, IgG exudation, <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> and <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>This protective effect was similar to that of pranlukast </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, HAMI 3339 at 10-100 ng i.c.v. is neuroprotective against <z:hpo ids='HP_0011009'>acute</z:hpo> brain injury after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest therapeutic potential for CysLT(2)R <z:chebi fb="68" ids="48706">antagonists</z:chebi> in the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>